Read + Share
Ozdemir HB, Ozdal PC. Reply on Comments on the paper "Clinical characteristics and treatment of pars
planitis: an adalimumab experience" by Ozdemir et al. Graefes Arch Clin Exp Ophthalmol 2022;260:2067.
PMID: 35088114
|
 |
|
Ozdemir HB, Ozdal PC. Reply on Comments on the paper "Clinical characteristics and treatment of pars
planitis: an adalimumab experience" by Ozdemir et al. Graefes Arch Clin Exp Ophthalmol 2022;260:2067.
PMID: 35088114
|
|
|
|